Your browser doesn't support javascript.
loading
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
Seydoux, Emilie; Liang, Hong; Dubois Cauwelaert, Natasha; Archer, Michelle; Rintala, Nicholas D; Kramer, Ryan; Carter, Darrick; Fox, Christopher B; Orr, Mark T.
Affiliation
  • Seydoux E; Infectious Disease Research Institute, Seattle, WA 98102; and.
  • Liang H; Infectious Disease Research Institute, Seattle, WA 98102; and.
  • Dubois Cauwelaert N; Infectious Disease Research Institute, Seattle, WA 98102; and.
  • Archer M; Infectious Disease Research Institute, Seattle, WA 98102; and.
  • Rintala ND; Infectious Disease Research Institute, Seattle, WA 98102; and.
  • Kramer R; Infectious Disease Research Institute, Seattle, WA 98102; and.
  • Carter D; Infectious Disease Research Institute, Seattle, WA 98102; and.
  • Fox CB; Department of Global Health, University of Washington, Seattle, WA 98195.
  • Orr MT; Infectious Disease Research Institute, Seattle, WA 98102; and.
J Immunol ; 201(1): 98-112, 2018 07 01.
Article in En | MEDLINE | ID: mdl-29769270
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Vaccines / B-Lymphocytes / Adjuvants, Immunologic / Th1 Cells / Toll-Like Receptor 4 / Inflammasomes / Antigens Language: En Journal: J Immunol Year: 2018 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Vaccines / B-Lymphocytes / Adjuvants, Immunologic / Th1 Cells / Toll-Like Receptor 4 / Inflammasomes / Antigens Language: En Journal: J Immunol Year: 2018 Type: Article